Thomas Dimartino
Family Medicine · Edenton, NCNPI 1003809542
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $992 and has fallen 96.3% since, to $36 in 2025.
Across 239 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$845
- Amgen$452
- Boehringer Ingelheim$359
- Johnson & Johnson$281
- Abbott$250
- Sanofi-aventis U.S. LLC$232
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,735100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 62 | $845 |
| Amgen | 21 | $452 |
| Boehringer Ingelheim | 20 | $359 |
| Johnson & Johnson | 20 | $281 |
| Abbott | 15 | $250 |
| Sanofi-aventis U.S. LLC | 14 | $232 |
| Pfizer | 13 | $195 |
| Novartis | 13 | $192 |
| Lilly USA, LLC | 12 | $174 |
| AstraZeneca | 9 | $126 |
| Merck | 7 | $110 |
| AbbVie(2 entities) | 5 | $90 |
| E.r. Squibb & Sons, L.L.C. | 4 | $69 |
| Astellas Pharma US Inc | 4 | $56 |
| Dexcom, Inc. | 3 | $52 |
| Amarin Pharma, Inc. | 3 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Kowa Pharmaceuticals America, Inc. | 3 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $17 |
| Mylan Specialty L.p. | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$125
How this compares
$3,735 in reported general payments places this provider in the 85th percentile of 3,444 family medicine providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alendronate Sodium | 11 | $251 |
| Amlodipine Besylate | 23 | $143 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Edenton
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.